Hanley Jr. Michael Conick 4
4 · Aeglea BioTherapeutics, Inc. · Filed Feb 22, 2022
Insider Transaction Report
Form 4
Hanley Jr. Michael Conick
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-17+160,000→ 160,000 totalExercise: $3.17Exp: 2032-02-16→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2022, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.